本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

9.36
+0.31003.43%
盘后9.360.00000.00%19:38 EDT
成交量:119.73万
成交额:1,121.61万
市值:5.11亿
市盈率:-5.68
高:9.60
开:9.07
低:9.05
收:9.05
数据加载中...
2021/11/08

重要事件披露

8-K - Current report
2021/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/09/21

重要事件披露

8-K - Current report
2021/09/09

重要事件披露

8-K - Current report
2021/08/10

重要事件披露

8-K - Current report
2021/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/30

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/09

重要事件披露

8-K - Current report
2021/05/14

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/03/19

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/09

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/09

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals